FDA Announces Proposed Collection of Information for Transfusion-Transmissible Infections Monitoring System

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as part of the Paperwork Reduction Act of 1995, to assess donor risk for the FDA/National Heart, Lung, and Blood Institute-sponsored Transfusion-Transmissible Infections Monitoring System.